The Biden administration is slowly shifting millions of Covid-19 treatments to private insurers and drugmakers, starting next week.

October 27, 2023 Check out STAT+

Sponsored By

Joe Raedle/Getty Images Paying for Covid pills will soon shift to insurers The Biden administration is slowly shifting millions of Covid-19 treatments to private insurers and drugmakers, starting next week. By Sarah Owermohle STAT+ | FDA has some safety concerns about CRISPR-based sickle cell treatment, documents show In documents disclosed ahead of a public hearing on Tuesday, the FDA found no fault with the efficacy of the sickle cell treatment, exa-cel. By Adam Feuerstein and Megan Molteni STAT+ | Why Sanofi got shellacked The Paris-based drug giant used a quarterly earnings announcement to make what appears to be a major strategic change. By Matthew Herper Gerald Herbert/AP Emergency medicine is grappling with a surprising problem: The prospect of too many physicians A 2021 study predicted that there would be a surplus of nearly 8,000 emergency physicians by 2030 in the U.S. By Brittany Trang STAT+ | In major test for prime editing, scientists successfully correct mutations in monkeys The David Liu company says its results with prime editing, the CRISPR-based technology, shows its potential to treat numerous diseases. By Jason Mast STAT+ | ARPA-H head Renee Wegrzyn on the agency's new Cambridge hub and plans for cancer research Renee Wegrzyn, director of ARPA-H, visited Cambridge for the launch of the agency's new Investor Catalyst Hub. By Theresa Gaffney Adobe Opinion: Excited delirium: a deadly term finally laid to rest The fake medical syndrome excited delirium is finally being laid to rest. Now comes the hard part. By Utsha G. Khatri

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2023, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser